Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.45 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.45 |
| ▸ | EYA3 | Q99504 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.40 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6139780 | 0.91 | EYA3 (0.50) | EYA3PTPN1NR1H4SIRT3TTR | |
| SCHEMBL6139677 | 0.91 | EYA3 (0.50) | EYA3PTPN1NR1H4SIRT3TTR | |
| SCHEMBL6140054 | 0.88 | ESR1 (0.49) | SIRT3ESR1PGRCHRM2HTR1A | |
| Oxalic Acid SCHEMBL6139576 | 0.86 | ESR1 (0.47) | SIRT3ESR1PGRCHRM2HTR1A | |
| SCHEMBL3250702 | 0.85 | NR1H4 (0.44) | CYP4F2CYP4A11EYA3PTPN1NR1H4 | |
| SCHEMBL6139790 | 0.85 | EYA3 (0.48) | EYA3PTPN1NR1H4SIRT3SLC22A12 | |
| Celivarone SCHEMBL3251183 | 0.82 | ESR1 (0.53) | ESR1PGRCHRM2HTR1AADRA2A | |
| Celivarone SCHEMBL29378821 | 0.82 | ESR1 (0.53) | ESR1PGRCHRM2HTR1AADRA2A | |
| Oxalic Acid SCHEMBL6139428 | 0.81 | ESR1 (0.51) | ESR1PGRCHRM2HTR1AADRA2A | |
| SCHEMBL6139739 | 0.81 | PTPN1 (0.50) | EYA3PTPN1NR1H4ESR1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6949583-B2 | Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same | SANOFI-SYNTHELABO (FR) | 2005-09-27 | — | — | US | disclosed |
| US-20030225100-A1 | Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same | SANOFI (FR) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225100-A1 | Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same | NR2C2, NR4A2, NR5A2 | CYP4F2 123/4885CYP4A11 130/4885EYA3 4589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.